Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

被引:184
作者
Feitelson, Mark A.
Lee, Jungmin
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
关键词
hepatitis B virus; hepatocellular carcinoma; hepatitis B x antigen; genetic changes; oncogenes; tumor suppressor genes; microRNAs; loss of heterozygosity; hepatocarcniogenesis; fragile sites; genetic instability; tumor suppressors;
D O I
10.1016/j.canlet.2006.11.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic liver disease associated with long term hepatitis B virus (HBV) infection contributes importantly to the development of hepatocellular carcinoma (HCC). A salient feature of these chronic infections is the integration of subgenomic HBV DNA fragments into many different locations within the host DNA, suggesting that integration is random. Although this may promote genetic instability during liver regeneration which accompanies a bout of chronic liver disease, the actual role of integrated HBV DNA in hepatocarcinogenesis is uncertain. Importantly, most integration events retain the HBV open reading frame encoding the HBx antigen (HBxAg), which is the virus contribution to HCC. In addition, many integration events reported in the literature occur near or within fragile sites or other cancer associated regions of the human genome that are prone to instability in tumor development and progression. Genetic instability associated with integration potentially alters the expression of oncogenes, tumor suppressor genes, and rnicroRNAs (miRNAs) that may contribute importantly to tumorigenesis. If so, then selected integration events may alter pathways that are rate limiting in hepatocarcinogenesis, thereby providing targets with diagnostic/prognostic potential and for therapeutic intervention. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:157 / 170
页数:14
相关论文
共 126 条
  • [1] FULL-LENGTH AND TRUNCATED VERSIONS OF THE HEPATITIS-B VIRUS (HBV) X-PROTEIN (PX) TRANSACTIVATE THE CMYC PROTOONCOGENE AT THE TRANSCRIPTIONAL LEVEL
    BALSANO, C
    AVANTAGGIATI, ML
    NATOLI, G
    DEMARZIO, E
    WILL, H
    PERRICAUDET, M
    LEVRERO, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (03) : 985 - 992
  • [2] Balsara BR, 2001, GENE CHROMOSOME CANC, V30, P245, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO
  • [3] 2-M
  • [4] Beasley R.P., 1984, VIRAL HEPATITIS LIVE, P209
  • [5] BEASLEY RP, 1981, LANCET, V2, P1129
  • [6] Hepatitis B virus X protein interferes with cellular DNA repair
    Becker, SA
    Lee, TH
    Butel, JS
    Slagle, BL
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (01) : 266 - 272
  • [7] Calcium signaling by HBx protein in hepatitis B virus DNA replication
    Bouchard, MJ
    Wang, LH
    Schneider, RJ
    [J]. SCIENCE, 2001, 294 (5550) : 2376 - 2378
  • [8] Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
    Calin, GA
    Sevignani, C
    Dan Dumitru, C
    Hyslop, T
    Noch, E
    Yendamuri, S
    Shimizu, M
    Rattan, S
    Bullrich, F
    Negrini, M
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) : 2999 - 3004
  • [9] Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis
    Chami, M
    Gozuacik, D
    Saigo, K
    Capiod, T
    Falson, P
    Lecoeur, H
    Urashima, T
    Beckmann, J
    Gougeon, ML
    Claret, M
    le Maire, M
    Bréchot, C
    Paterlini-Bréchot, P
    [J]. ONCOGENE, 2000, 19 (25) : 2877 - 2886
  • [10] Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma
    Chen, YJ
    Yeh, SH
    Chen, JT
    Wu, CC
    Hsu, MT
    Tsai, SF
    Chen, PJ
    Lin, CH
    [J]. GASTROENTEROLOGY, 2000, 119 (02) : 431 - 440